Genscript Biotech Corporation (FRA:G51)
Germany · Delayed Price · Currency is EUR 1.342
+0.065 (5.13%)
At close: Feb 20, 2026
-10.57% (1Y)
| Market Cap | 2.86B +3.3% |
| Revenue (ttm) | 705.13M +63.2% |
| Net Income | 2.65B |
| EPS | 1.20 |
| Shares Out | n/a |
| PE Ratio | 1.08 |
| Forward PE | 31.46 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,498 |
| Average Volume | 318 |
| Open | 1.291 |
| Previous Close | 1.276 |
| Day's Range | 1.291 - 1.342 |
| 52-Week Range | 1.119 - 2.042 |
| Beta | n/a |
| RSI | 48.53 |
| Earnings Date | Mar 11, 2026 |